AMBEA 📈 Ambea AB - Overview

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0009663826

AMBEA: Elderly Care, Disability Care, Social Support, Nursing Homes, Home Care

Ambea AB is a leading provider of care services, operating primarily in Sweden, Norway, and Denmark, with a focus on elderly care, disability care, and psychosocial support. The company's services are divided into five main segments: Nytida, Vardaga, Stendi, Altiden, and Klara, each catering to specific needs and demographics. For instance, Nytida offers social care services and specialized schools for children and young people with neuropsychiatric disorders, while Vardaga provides nursing homes and home care services for elderly individuals. This diversified approach enables Ambea AB to address a wide range of care requirements, from childhood to old age.

The company's Stendi segment is dedicated to providing social care for children, young people, and adults, with a range of services including personal assistance, residential care, home care, and elderly care. In contrast, the Altiden segment focuses on elderly care, disability care, nursing homes, home care, and rehabilitation services, highlighting the company's commitment to supporting vulnerable populations. Additionally, Ambea AB's Klara brand offers staffing solutions for schools and social care, as well as ambulatory care teams and student health and rehabilitation services, further expanding its reach and capabilities.

Ambea AB also recognizes the importance of skills development and training in the care services sector, which is why it has established the Lära brand. This initiative provides coaching services and training programs in disability care, social services, aged care, and schools, aiming to enhance the expertise and competence of care professionals. With a history dating back to 1993, Ambea AB has established itself as a major player in the Nordic care services market, with its headquarters located in Solna, Sweden. The company's common stock is listed under the ISIN code SE0009663826, and it is classified under the GICS Sub Industry of Health Care Facilities.

As a key player in the health care facilities sector, Ambea AB is well-positioned to address the evolving needs of the Nordic care services market. With its diversified portfolio of brands and services, the company is able to provide comprehensive support to individuals across various age groups and care requirements. By investing in skills development and training, Ambea AB is also contributing to the growth and professionalization of the care services sector, ultimately benefiting the individuals and communities it serves. For more information about Ambea AB, please visit its website at https://www.ambea.se.

Additional Sources for AMBEA Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AMBEA Stock Overview

Market Cap in USD 777m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

AMBEA Stock Ratings

Growth 5y 28.0%
Fundamental 66.3%
Dividend 43.9%
Rel. Strength Industry 4035
Analysts -
Fair Price Momentum 107.22 SEK
Fair Price DCF 566.15 SEK

AMBEA Dividends

Dividend Yield 12m 1.54%
Yield on Cost 5y 2.12%
Annual Growth 5y 2.59%
Payout Consistency 70.7%

AMBEA Growth Ratios

Growth Correlation 3m 86.1%
Growth Correlation 12m 98.4%
Growth Correlation 5y 4.1%
CAGR 5y 6.49%
CAGR/Mean DD 5y 0.23
Sharpe Ratio 12m 2.14
Alpha 69.09
Beta 0.74
Volatility 33.66%
Current Volume 225.6k
Average Volume 20d 213.5k
What is the price of AMBEA stocks?
As of December 21, 2024, the stock is trading at SEK 97.15 with a total of 225,627 shares traded.
Over the past week, the price has changed by -1.22%, over one month by +4.74%, over three months by +7.40% and over the past year by +96.41%.
Is Ambea AB a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Ambea AB (ST:AMBEA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 66.33 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMBEA as of December 2024 is 107.22. This means that AMBEA is currently undervalued and has a potential upside of +10.37% (Margin of Safety).
Is AMBEA a buy, sell or hold?
Ambea AB has no consensus analysts rating.
What are the forecast for AMBEA stock price target?
According to ValueRays Forecast Model, AMBEA Ambea AB will be worth about 116.9 in December 2025. The stock is currently trading at 97.15. This means that the stock has a potential upside of +20.32%.
Issuer Forecast Upside
Wallstreet Target Price 115.3 18.7%
Analysts Target Price - -
ValueRay Target Price 116.9 20.3%